tetano
Editor, Senior Moderator
Virology
. 2021 Dec 10;566:143-152.
doi: 10.1016/j.virol.2021.12.003. Online ahead of print.
Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes
Bo Ryoung Park[SUP] 1 [/SUP], Jeeva Subbiah[SUP] 1 [/SUP], Ki-Hye Kim[SUP] 1 [/SUP], Young-Man Kwon[SUP] 1 [/SUP], Judy Oh[SUP] 1 [/SUP], Min-Chul Kim[SUP] 2 [/SUP], Chong-Hyun Shin[SUP] 1 [/SUP], Baik Lin Seong[SUP] 3 [/SUP], Sang-Moo Kang[SUP] 4 [/SUP]
Affiliations
Abstract
Annual repeat influenza vaccination raises concerns about protective efficacy against mismatched viruses. We investigated the impact of heterologous prime-boost vaccination on inducing cross protection by designing recombinant influenza viruses with chimeric hemagglutinin (HA) carrying M2 extracellular domains (M2e-HA). Heterologous prime-boost vaccination of C57BL/6 mice with M2e-HA chimeric virus more effectively induced M2e and HA stalk specific IgG antibodies correlating with cross protection than homologous prime-boost vaccination. Induction of M2e and HA stalk specific IgG antibodies was compromised in 1-year old mice, indicating significant aging effects on priming subdominant M2e and HA stalk IgG antibody responses. This study demonstrates that a heterologous prime-boost strategy with recombinant influenza virus expressing extra M2e epitopes provides more effective cross protection than homologous vaccination.
Keywords: Cross protection; Live attenuated virus; M2e; Recombinant influenza virus.
. 2021 Dec 10;566:143-152.
doi: 10.1016/j.virol.2021.12.003. Online ahead of print.
Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes
Bo Ryoung Park[SUP] 1 [/SUP], Jeeva Subbiah[SUP] 1 [/SUP], Ki-Hye Kim[SUP] 1 [/SUP], Young-Man Kwon[SUP] 1 [/SUP], Judy Oh[SUP] 1 [/SUP], Min-Chul Kim[SUP] 2 [/SUP], Chong-Hyun Shin[SUP] 1 [/SUP], Baik Lin Seong[SUP] 3 [/SUP], Sang-Moo Kang[SUP] 4 [/SUP]
Affiliations
- PMID: 34929590
- DOI: 10.1016/j.virol.2021.12.003
Abstract
Annual repeat influenza vaccination raises concerns about protective efficacy against mismatched viruses. We investigated the impact of heterologous prime-boost vaccination on inducing cross protection by designing recombinant influenza viruses with chimeric hemagglutinin (HA) carrying M2 extracellular domains (M2e-HA). Heterologous prime-boost vaccination of C57BL/6 mice with M2e-HA chimeric virus more effectively induced M2e and HA stalk specific IgG antibodies correlating with cross protection than homologous prime-boost vaccination. Induction of M2e and HA stalk specific IgG antibodies was compromised in 1-year old mice, indicating significant aging effects on priming subdominant M2e and HA stalk IgG antibody responses. This study demonstrates that a heterologous prime-boost strategy with recombinant influenza virus expressing extra M2e epitopes provides more effective cross protection than homologous vaccination.
Keywords: Cross protection; Live attenuated virus; M2e; Recombinant influenza virus.